<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-01-28">28 January 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">D</forename><surname>Nurjadi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Infectious Diseases</orgName>
								<orgName type="department" key="dep2">Medical Microbiology and Hygiene</orgName>
								<orgName type="institution">Heidelberg University Hospital</orgName>
								<address>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute of Tropical Medicine</orgName>
								<orgName type="institution">Eberhard Karls Universität</orgName>
								<address>
									<settlement>Tübingen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">B</forename><surname>Friedrich-Jänicke</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Tropical Medicine and International Health</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Spandauer Damm</addrLine>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Schäfer</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Paul-Lechler-Krankenhaus</orgName>
								<address>
									<settlement>Tropenklinik, Tübingen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><forename type="middle">J J</forename><surname>Van Genderen</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Instituut voor Tropische Ziekten</orgName>
								<address>
									<settlement>Havenziekenhuis, Rotterdam</settlement>
									<region>TG</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Goorhuis</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Centre of Tropical Medicine and Travel Medicine</orgName>
								<orgName type="department" key="dep2">Department of Infectious Diseases</orgName>
								<orgName type="department" key="dep3">Academic Medical Centre</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<settlement>Amsterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Perignon</surname></persName>
							<affiliation key="aff6">
								<orgName type="laboratory">Service de Maladies Infectieuses et Tropicales</orgName>
								<orgName type="institution">Groupe Hospitalier Pitié-Salpêtrière</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Neumayr</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">Swiss Tropical and Public Health Institute</orgName>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">University of Basel</orgName>
								<address>
									<addrLine>10) Missionsärztliche Klinik</addrLine>
									<settlement>Basel, Würzburg, Germany</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Mueller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Kantele</surname></persName>
							<affiliation key="aff9">
								<orgName type="department" key="dep1">Division of Infectious Diseases</orgName>
								<orgName type="department" key="dep2">Department of Medicine</orgName>
								<orgName type="institution">Helsinki University Central Hospital</orgName>
								<address>
									<settlement>Helsinki</settlement>
									<country key="FI">Finland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Schunk</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">Abteilung für Infektions-und Tropenmedizin</orgName>
								<orgName type="institution">Ludwig-Maximilians-Universität</orgName>
								<address>
									<addrLine>13) ISGlobal</addrLine>
									<settlement>München, Germany</settlement>
								</address>
							</affiliation>
							<affiliation key="aff11">
								<orgName type="department">Biostatistics and Prevention Institute</orgName>
								<orgName type="institution" key="instit1">Barcelona Centre for International Health Research (CRESIB)</orgName>
								<orgName type="institution" key="instit2">Hospital Clínic -Universitat de Barcelona</orgName>
								<address>
									<addrLine>14) Epidemiology</addrLine>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="institution">University of Zürich</orgName>
								<address>
									<settlement>Zürich</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Gascon</surname></persName>
						</author>
						<author>
							<persName><forename type="first">A</forename><surname>Stich</surname></persName>
						</author>
						<author>
							<persName><forename type="first">C</forename><surname>Hatz</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">Swiss Tropical and Public Health Institute</orgName>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="institution">University of Basel</orgName>
								<address>
									<addrLine>10) Missionsärztliche Klinik</addrLine>
									<settlement>Basel, Würzburg, Germany</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">E</forename><surname>Caumes</surname></persName>
							<affiliation key="aff6">
								<orgName type="laboratory">Service de Maladies Infectieuses et Tropicales</orgName>
								<orgName type="institution">Groupe Hospitalier Pitié-Salpêtrière</orgName>
								<address>
									<settlement>Paris</settlement>
									<country key="FR">France</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Grobusch</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Centre of Tropical Medicine and Travel Medicine</orgName>
								<orgName type="department" key="dep2">Department of Infectious Diseases</orgName>
								<orgName type="department" key="dep3">Academic Medical Centre</orgName>
								<orgName type="institution">University of Amsterdam</orgName>
								<address>
									<addrLine>The Netherlands</addrLine>
									<settlement>Amsterdam</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">R</forename><surname>Fleck</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution">Paul-Lechler-Krankenhaus</orgName>
								<address>
									<settlement>Tropenklinik, Tübingen, Germany</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Mockenhaupt</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Tropical Medicine and International Health</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Spandauer Damm</addrLine>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Zanger</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Tropical Medicine</orgName>
								<orgName type="institution">Eberhard Karls Universität</orgName>
								<address>
									<settlement>Tübingen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Institute of Public Health</orgName>
								<orgName type="department" key="dep2">Unit of Epidemiology and Biostatistics</orgName>
								<orgName type="institution">Heidelberg University Hospital</orgName>
								<address>
									<settlement>Heidelberg</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Lina</surname></persName>
						</author>
						<author>
							<affiliation key="aff14">
								<orgName type="department">24th European Congress of Clinical Microbiology and Infectious Diseases</orgName>
								<address>
									<settlement>Barcelona</settlement>
									<country key="ES">Spain</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff15">
								<orgName type="department">Institute of Public Health</orgName>
								<orgName type="institution">Uni-versity Hospital</orgName>
								<address>
									<addrLine>Im Neuenheimer Feld 324</addrLine>
									<postCode>69120</postCode>
									<settlement>Heidelberg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Skin and soft tissue infections in intercontinental travellers and the import of multi-resistant Staphylococcus aureus to Europe</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-01-28">28 January 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">96A3F3F82019D471068EF74F4170DEDF</idno>
					<idno type="DOI">10.1016/j.cmi.2015.01.016</idno>
					<note type="submission">Original Submission: 16 November 2014; Revised Submission: 28 December 2014; Accepted: 16 January 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:50+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Drug resistance</term>
					<term>emerging communicable diseases</term>
					<term>methicillin-resistant Staphylococcus aureus</term>
					<term>molecular epidemiology</term>
					<term>Panton-Valentine leukocidin</term>
					<term>risk factors</term>
					<term>sentinel surveillance</term>
					<term>staphylococcal skin infections</term>
					<term>travel medicine</term>
					<term>trimethoprimsulfamethoxazole combination</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Staphylococcus aureus is emerging globally.</s><s>Treatment of infections is complicated by increasing antibiotic resistance.</s><s>We collected clinical data and swabs of returnees with skin and soft tissue infections (SSTI) at 13 travel-clinics in Europe (www.staphtrav.eu).</s><s>Sixty-two percent (196/ 318) SSTI patients had S. aureus-positive lesions, of which almost two-thirds (122/196) were Panton-Valentine leukocidin (PVL) positive.</s><s>PVL was associated with disease severity, including hospitalization for SSTI (OR 5.2, 95% CI 1.5-18.2).</s><s>In returnees with SSTI, longer travel and more intense population contact were risk factors for nasal colonization with PVL-positive S. aureus.</s><s>Imported S. aureus frequently proved resistant to trimethoprim-sulfamethoxazole (21%), erythromycin (21%), tetracycline (20%), ciprofloxacin (13%), methicillin (12%) and clindamycin (8%).</s><s>Place of exposure was significantly (p &lt; 0.05) associated with predominant resistance phenotypes and spa genotypes: Latin America (methicillin; t008/CC24/304), Africa (tetracycline, trimethoprim-sulfamethoxazole; t084/CC84, t314/singleton, t355/ CC355), South Asia (trimethoprim-sulfamethoxazole, ciprofloxacin; t021/CC21/318), South-East Asia (clindamycin; t159/CC272).</s><s>USA300-like isolates accounted for 30% of all methicillin-resistant S. aureus imported to Europe and were predominantly (71%) acquired in Latin America.</s><s>Multi-resistance to non-β-lactams were present in 24% of imports and associated with travel to South Asia (OR crude 5.3, 95% CI 2.4-11.8),</s><s>even after adjusting for confounding by genotype (OR adjusted 3.8, 95% 1.5-9.5).</s><s>Choosing randomly from compounds recommended for the empiric treatment of severe S. aureus SSTI, 15% of cases would have received ineffective antimicrobial therapy.</s><s>These findings call for the development of regionally stratified guidance on the antibiotic management of severe imported S. aureus disease and put the infected and colonized traveller at the centre of interventions against the global spread of multi-resistant S. aureus.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Skin abscesses account for about 1% of all post-travel consultations <ref type="bibr" target="#b0">[1]</ref> with Staphylococcus aureus being by far their most common cause <ref type="bibr" target="#b2">[2,</ref><ref type="bibr" target="#b3">3]</ref>.</s><s>Incision and drainage is the therapy of choice, but complicated skin and soft tissue infection (SSTI) characterized by deep tissue involvement, extensive inflammation, recurrence and household clustering has become an increasingly recognized entity in travel medicine <ref type="bibr" target="#b4">[4]</ref><ref type="bibr" target="#b5">[5]</ref><ref type="bibr" target="#b6">[6]</ref>.</s><s>In these cases, the empiric choice of antibiotic compound can be a true challenge because the prevalence of resistance to both, methicillin and oral non-β-lactams in imported S. aureus is largely unknown.</s><s>Accordingly, existing recommendations for the treatment of severe SSTI cannot provide guidance on the empiric choice of antibiotic for returning travellers <ref type="bibr" target="#b7">[7]</ref><ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref> although the increased incidence and virulence of S. aureus SSTI in this population clearly indicate a need.</s></p><p><s>Here, we (i) describe the clinical and microbiological characteristics and risk factors of SSTI among intercontinental travellers consulting a sentinel network of European travel clinics; (ii) characterize imported S. aureus with respect to resistance phenotype, genotype and virulence genes; and (iii) analyse mutual associations between clinical presentation, strain characteristics and geographic exposure.</s><s>With our results, we aim to inform (i) treatment decisions for travel-associated SSTI, (ii) the content of pre-travel counselling and (iii) population level measures against the global spread of virulent and antibiotic-resistant staphylococci.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head><p><s>Patients with travel-associated SSTI have been prospectively identified since 2011 in a sentinel surveillance network on imported S. aureus comprising several participating travel clinics in Europe (www.staphtrav.eu).</s><s>Contributors anonymously submit one lesion swab and one nasal swab from patients with travelassociated SSTI to a centralized laboratory in Germany.</s><s>For inclusion, a patient has to (i) suffer from a skin infection on the day of the clinic visit, (ii) have returned from a trip outside Europe, and (iii) have experienced onset of SSTI while abroad or within 30 days after the end of the journey.</s><s>In addition, brief demographic, travel and clinical characteristics of the patient are documented.</s><s>This report presents the analysis of specimens and data collected from May 2011 to December 2013.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Bacterial culture</head><p><s>Swab materials delivered by mail or international courier service were cultured on mannitol-salt agar, selective for staphylococci, within 12 h after arrival at the study centre's laboratory.</s><s>Colonies showing mannitol fermentation were subcultivated on Columbia Agar with 5% sheep blood, tested for bound and free coagulase, and confirmed as S. aureus by amplification of the coa gene <ref type="bibr" target="#b10">[10]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibiotic susceptibility testing</head><p><s>Antimicrobial susceptibility was determined by disc diffusion according to the European Committee on Antimicrobial Susceptibility Testing.</s><s>The antimicrobial agents tested were cefoxitin, trimethoprim-sulfamethoxazole, clindamycin, erythromycin, ciprofloxacin, tetracycline, gentamicin and rifampicin (Becton Dickinson, Heidelberg, Germany).</s><s>Inducible clindamycin resistance was tested for all isolates resistant to erythromycin and susceptible to clindamycin <ref type="bibr" target="#b11">[11]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Resistance and virulence genes</head><p><s>All strains were tested for mecA and Panton-Valentine leukocidin (PVL) (lukS/lukF) by PCR <ref type="bibr" target="#b12">[12]</ref>.</s><s>The SCCmec types I-V of all methicillin-resistant S. aureus (MRSA) were determined by PCR <ref type="bibr" target="#b13">[13]</ref>.</s><s>MRSA isolates of spa type t008 were tested for the arginine catabolic mobile element ACME-arcA <ref type="bibr" target="#b14">[14]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Spa typing and multi locus sequencing</head><p><s>All S. aureus isolates were characterized by spa genotyping (http://www.spaserver.ridom.de)</s><s><ref type="bibr" target="#b15">[15]</ref>.</s><s>Spa types were clustered into spa clonal complexes (spa-CC) using the Based Upon Repeat Pattern (BURP) algorithm with parameters set to exclude if repeats were &lt;5 and to cluster if cost 4 <ref type="bibr" target="#b16">[16]</ref>.</s><s>negative, SCCmec IVc carrying isolates of spa t008 were considered Latin American Variants <ref type="bibr" target="#b18">[18]</ref>.</s><s>Univariable and multivariable logistic regression analyses were used to calculate odds ratios, 95% confidence intervals, and p-values for the analysis of clinical and microbiological characteristics.</s><s>All statistical procedures were performed using Stata 12.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Ethics</head><p><s>The study was approved by the Ethics Committee, Faculty of Medicine, Eberhard Karls Universität, Tübingen and by the institutional review boards of the contributing centres, if necessary.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Thirteen centres (Amsterdam, Barcelona, Basel, Berlin, Hamburg, Helsinki, Munich, Paris, Rotterdam, Tübingen (two), Vienna and Würzburg) submitted 351 lesional swabs.</s><s>Thirtythree submissions were excluded because of protocol violations (travel inside Europe, n = 7; onset of SSTI &gt;30 days after return, n = 8; non-travelling secondary cases, n = 5) or clustering (SSTI in co-travellers, n = 13), leaving 318 independent cases for the main analysis (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Of these 318 submissions, 196 (62%) were positive for S. aureus, 122 of 196 staphylococci contained PVL encoding genes, 23 of 196 staphylococci were MRSA, and 22 of 23 MRSA were PVL + .</s><s>Cases had a median age of 31 years (interquartile range 24 to 48 years) and were predominantly male (59%).</s><s>Predominating travel destinations were Africa (n = 102) and South-East Asia (n = 92).</s><s>Median travel duration was 28 days (interquartile range 17-91 days).</s><s>Primary purpose of travel was leisure (60%), followed by voluntary aid work (21%); visiting friends and relatives (10%); business (5%); and education (4%).</s><s>Ninety-nine (31%) of 318 cases with complete information reported recurrent disease, 85 of 317 (27%) surgical drainage, 50 of 316 (16%) SSTI in close contacts, 257 of 317 (81%) use of antibiotics for the treatment of SSTI, and 39 of 313 (12%) hospitalization due to travel-associated SSTI (Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Of 196 imported S. aureus, five were not spa typeable; one spa type was not performed.</s><s>The remaining 190 isolates belonged to 96 spa types and 16 spa clonal complexes: CC24/ 304, n = 24; CC21/318, n = 24; CC2, n = 16; CC84, n = 13; CC355, n = 13; CC272, n = 12; CC127, n = 12; CC345, n = 7; CC34, n = 5; CC15, n = 3; CC131, n = 3; five clusters with no founder, n = 11.</s><s>Forty-two strains (27% of all spa types) were singletons and five isolates were excluded for short repeats.</s><s>The genotypic characteristics of imported S. aureus by methicillin-resistance, PVL status and travel destination are summarized in the Supporting information (Fig. <ref type="figure">S1</ref>) and Tables <ref type="table" target="#tab_2">2 and 3</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Staphylococcus aureus-positive SSTI</head><p><s>Among all patients with travel-associated SSTI (Table <ref type="table" target="#tab_0">1</ref>, left column), returnees with S. aureus-positive lesions tended to be younger than patients with non-staphylococcal SSTI; also they were somewhat less likely to have visited South Asia, and were more often humanitarian mission travellers or visiting friends and relatives.</s><s>Clinically, S. aureus-positive lesions were found to be more likely to present as deep lesions that require surgical drainage and to cause recurrent disease, but less likely to present as ulcers, and to be preceded by insect bites or other minor trauma.</s><s>The proportion of S. aureus-positive lesions among all lesions did not differ with sex, travel duration, antibiotic treatment, inpatient treatment, anatomic location of lesion or report of contact persons being ill with SSTI.</s></p><p><s>PVL-positive SSTI Among S. aureus-positive SSTI, PVL was more often observed in isolates imported from Africa and Latin America and less often in those from the Pacific region and South-East Asia (Table <ref type="table" target="#tab_0">1</ref>, central column).</s><s>The PVL + , compared with PVL-negative (PVL -), S. aureus was strongly associated with abscess formation, recurrent disease, surgical drainage and lesions above the waistline.</s><s>Patients with PVL + lesions were more likely to require inpatient treatment when compared with travellers with SSTI caused by PVL -S.</s><s>aureus.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MRSA SSTI</head><p><s>Methicillin-resistant S. aureus accounted for 7% (23/318) of all travel-associated SSTI and for 12% <ref type="bibr">(23/196</ref>) of all S. aureus-positive cases.</s><s>Travel to Latin America and for humanitarian purposes or visiting friends and relatives were independent risk factors for acquisition of MRSA (crude ORs, Table <ref type="table" target="#tab_0">1</ref>, right column; mutually adjusted ORs from multivariable model are, for Latin America, 5.47, 95% CI 2.09-24.33,</s><s>p 0.001 and, for visiting friends and relatives, 2.84, 95% CI 1.13-7.15,</s><s>p 0.03).</s><s>Compared with travellers with methicillin-susceptible S. aureus (MSSA), cases with MRSA-related SSTI were more likely to report skin infections in contact persons (Table <ref type="table" target="#tab_0">1</ref>, right column).</s></p><p><s>Seven of 23 independent MRSA imports (30%) were PVL + and spa type t008: four of the seven were SCCmec type IVa, arcApositive and three of the seven were SCCmec IVc, arcA-negative, consistent with the USA300-0114 and USA300-Latin American Variant lineages, respectively <ref type="bibr" target="#b18">[18]</ref>.</s><s>Five (71%) of these seven potential USA300 were imported from Latin America (Table <ref type="table" target="#tab_2">3</ref>).</s><s>Other community-associated MRSA imported from the Philippines and India revealed spa genotypes that are known to be associated with the South-West Pacific (spa t019) <ref type="bibr" target="#b19">[19]</ref> and the Bay of Bengal (spa t657) <ref type="bibr" target="#b20">[20]</ref> clones (Table <ref type="table" target="#tab_2">3</ref>).</s><s>e Countries (number of independent isolates) included were Pakistan (1), India <ref type="bibr" target="#b19">(19)</ref>, Sri Lanka (7), Nepal (5), f Countries (number of independent isolates) included were Thailand <ref type="bibr" target="#b25">(25)</ref>, Laos (3), Vietnam (4), Cambodia (2), Indonesia (8), Malaysia (3), Singapore (2), Philippines <ref type="bibr" target="#b10">(10)</ref>.</s></p><p><s>g Countries (number of independent isolates) included were Australia (1), Papua New Guinea (4), New Zealand (1), Fiji (2).</s><s>h Eight of these 15 isolates were resistant to erythromycin and had a positive D-test, consistent with inducible resistance to clindamycin.</s><s>i Probability of failure of empiric therapy assuming a random selection from currently recommended, orally bioavailable first-line and second-line compounds for the treatment of S. aureus SSTI, i.e. isoxazolyl penicillins, trimethoprim-sulfamethoxazole, tetracyclines, or clindamycin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Nasal carriage</head><p><s>Nasal swabs were available for 310 of the 318 cases analysed.</s><s>Of these, 39% (122/310) were nasal carriers of S. aureus, 17% (53/310) of PVL + S. aureus, and 6% (18/310) of MRSA.</s><s>Table <ref type="table" target="#tab_3">4</ref> summarizes risk factors of various types of S. aureus nasal carriage and their association with clinical characteristics of SSTI in travellers.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antimicrobial (multi-)resistance</head><p><s>Nearly half of all imported S. aureus (89/196) were resistant to at least one compound currently used for the empiric treatment of SSTI (i.e.</s><s>isoxazolyl-penicillins, trimethoprim-sulfamethoxazole, tetracycline, clindamycin), 49% (96/196) were resistant to at least one non-β-lactam, and 54% (106/196) to at least one of the compounds tested in this study.</s><s>Frequency and patterns of antimicrobial resistance in imported S. aureus varied largely by place of exposure abroad (Table <ref type="table" target="#tab_1">2</ref>; see Supporting information, Fig. <ref type="figure">S2</ref>).</s></p><p><s>Resistance to two, three, four or seven of the tested compounds simultaneously was observed in 16% (32/196), 8% (15/ 196), 3% (6/196) and 0.5% (1/196) of imported isolate(s), respectively.</s><s>Multi-resistance to two or more of any of the tested antibiotics was associated with travel to South Asia, various clinical characteristics of severe SSTI, PVL-positivity, methicillinresistance and the spa types t021 and t008 (Table <ref type="table" target="#tab_6">5</ref>, left column).</s><s>Multi-resistance to two, three, four or seven non-β-lactam antibiotics simultaneously was found in 13% (26/196), 8% (16/ 196), 1.5% (3/196) and 0.5% (1/196) of isolate(s) and was associated with travel to South Asia, various clinical characteristics of severe SSTI, PVL-positivity, and the spa types t355 and t021, but not with concomitant methicillin resistance or spa type t008 (Table <ref type="table" target="#tab_6">5</ref>, central column).</s><s>To assess whether clonality confounded the effect of exposure in South Asia on multiresistance to non-β-lactams in S. aureus, we fitted a multivariable logistic regression model adjusting for those spa types that were associated with both multi-resistance and South Asia.</s><s>After adjusting for some positive confounding, exposure in South Asia remained a strong and independent predictor of multi-resistance to non-β-lactams in imported S. aureus (Table <ref type="table" target="#tab_6">5</ref>, right column).</s></p><p><s>Choosing randomly from antibiotic compounds recommended for the empiric treatment of skin and soft-tissue infections (i.e.</s><s>isoxazolyl-penicillins, trimethoprimsulfamethoxazole, tetracycline, clindamycin) <ref type="bibr" target="#b7">[7]</ref><ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref>, there was an overall 15% chance to treat any of the returnees included in this study ineffectively (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this European multi-centre study, we found that antimicrobial (multi-)resistance in imported S. aureus is common and its geographic distribution is globally heterogeneous.</s><s>We</s></p><p><s>.0) 0.9 Humanitarian/VFR (36) 52  estimated that overall 12% of all S. aureus causing SSTI in intercontinental travellers is MRSA and observed that SSTI in returnees from Latin America promotes the spread of the highly virulent USA300 community-associated MRSA lineage.</s><s>This finding is in line with reports on the expansion of USA300 from the USA into Latin America <ref type="bibr" target="#b21">[21,</ref><ref type="bibr" target="#b22">22]</ref> and from there to Europe <ref type="bibr" target="#b23">[23]</ref>.</s><s>Besides, we provide evidence for a less prominent import of the pandemic South-West Pacific and the emerging Bay of Bengal community-associated-MRSA clones to Europe by travellers returning from the Philippines and India.</s><s>We show that resistance to non-β-lactam antibiotics in imported S. aureus is common, amounting to 50% of all isolates, depending on destination and antimicrobial class tested.</s><s>Besides, we demonstrate that about one-quarter of S. aureus causing SSTI abroad are multi-resistant and that travel to South Asia independently predicts multi-resistance to non-β-lactams in these bacteria.</s><s>Taken together, these findings challenge the unguided use of trimethoprim-sulfamethoxazole, tetracycline derivatives and clindamycin against presumed MRSA infections in returning travellers <ref type="bibr" target="#b7">[7]</ref><ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref> and support the concept of regionally adapted treatment recommendations <ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref><ref type="bibr" target="#b26">[26]</ref>.</s><s>Furthermore, our observations allow the assumption of a regionally high prevalence of resistance to non-β-lactam antibiotics in parts of Africa and Asia.</s><s>This extrapolation is supported by our recent finding of similar resistance gene content in S. aureus collected from native Africans and travellers returning from that continent <ref type="bibr" target="#b27">[27,</ref><ref type="bibr" target="#b28">28]</ref>.</s><s>Along this line, the presented data suggest that the use of tetracycline and trimethoprim-sulfamethoxazole as region-specific empiric antibiotic treatment of community-associated MRSA SSTIs in Africa and Asia is limited considering that a substantial proportion of suspected cases will ultimately be caused by MSSA because of a lack of reliable predictors of methicillin resistance.</s><s>Hence, future recommendations on the empiric antibiotic treatment of community-associated SSTI should incorporate resistance data gathered in MSSA and MRSA isolates alike.</s><s>Following this rationale, we would like to challenge a recent review that looked at antibiotic resistance patterns in community MRSA globally and concluded that trimethoprimsulfamethoxazole is an effective 'region-specific empiric antibiotic treatment [in] Asia' <ref type="bibr" target="#b24">[24]</ref>.</s><s>Of note, we observed that those S. aureus lineages that were strongly associated with multi-resistance to non-β-lactam antibiotics (spa t021 and t355, Table <ref type="table" target="#tab_6">5</ref>) were also commonly PVLpositive (91% and 100%; Fig. <ref type="figure">S1</ref>).</s><s>This is alarming since PVL + MSSA is thought to represent the reservoir from which at least some of the successful epidemic community-associated MRSA clones emerged through horizontal genetic exchange <ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref>. Hence, the relative abundance of multi-resistant PVL + MSSA among imported staphylococci could herald the evolution of multi-resistant MRSA lineages in the community.</s><s>This is in contrast to current practice in research, surveillance and control of multi-resistant S. aureus that largely neglects antibiotic resistance in MSSA and tends to focus on methicillin-resistant lineages instead.</s><s>Better knowledge on the accumulation of multi-resistance in MSSA as presented here is needed to contain potential methicillin-sensitive precursors of multiresistant community-associated MRSA.</s></p><p><s>Nearly two-thirds of S. aureus causing SSTI in intercontinental travellers were found to be PVL + and the lukS/lukF genes were strong predictors of SSTI-associated morbidity.</s><s>In addition to confirming its known associations with recurrent and deep-seated abscesses <ref type="bibr" target="#b6">[6,</ref><ref type="bibr" target="#b23">23]</ref>, we were able to demonstrate that SSTIs caused by PVL + S. aureus were more likely to lead to hospitalization.</s><s>According to a recent review <ref type="bibr" target="#b23">[23]</ref>, this has not been shown in an adult population before.</s><s>Taking into account the geographic and genetic diversity of S. aureus in our study, this finding supports the concept that PVL has indeed an effect on disease outcome rather than being merely linked with other virulence factors-a common shortcoming of research into infections from geographically confined populations and in clonally related S. aureus <ref type="bibr" target="#b23">[23]</ref>.</s></p><p><s>Nasal carriage of PVL + S. aureus proved to be a risk factor for recurrent abscesses and was associated with SSTI lesions being located above the waistline.</s><s>These observations suggest that PVL + strains, compared with PVLstaphylococci, are more likely to cause manifest skin infections when spread from the nose to areas of the body that are within the direct reach of the hands.</s><s>This emphasizes the role of colonized human nares in perpetuating PVL + SSTI and supports empiric nasal decolonization therapy for secondary prevention of recurrent posttravel SSTI.</s><s>Of note, we found longer duration of travel, humanitarian aid work, and visiting friends and relatives to be risk factors for nasal carriage of PVL + S. aureus.</s><s>This knowledge may prove useful when tailoring the content of pre-travel consultations and targeting infection prevention measures.</s></p><p><s>In summary, the presented findings illustrate that sentinel surveillance of S. aureus infecting travellers is an efficient way of providing information on antimicrobial resistance in as yet understudied regions, call for the development of regionally stratified guidance on the antibiotic management of severe imported S. aureus disease, and put the infected and colonized traveller at the centre of interventions against the global spread of multi-resistant S. aureus.</s><s>Our network will continue this surveillance with the aim of detecting newly emerging clones and monitoring trends of antimicrobial resistance in imported S. aureus over time.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>c Countries (number of isolates) included were Mexico<ref type="bibr" target="#b0">(1)</ref>, Nicaragua (1), Costa Rica (2), Panama (1), Cuba (1), Haiti (1), Bahamas (1), Dominican Republic (9), Jamaica (1), Columbia (3), Surinam (4), Ecuador (1), Peru (1), Brazil (3), Paraguay (2).</s><s>d Countries (number of isolates) included were Morocco (1), Tunisia (1), Sudan (1), Niger (1), Cape Verde (1) Senegal (1), Gambia (3), Guinea Bissau (1), Equatorial Guinea (1), Sierra Leone (2), Ghana<ref type="bibr" target="#b6">(6)</ref>, Togo (1), Benin (1), Nigeria (2), Cameroon (5), Democratic Republic of Congo (1), Republic of Congo (2), Rwanda (1), Burundi (1), Kenya<ref type="bibr" target="#b10">(10)</ref>, Uganda (4), Tanzania (4), Mozambique (2), Madagascar (2), Zambia (3), Malawi (3), South Africa (1), Namibia (1).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 .</head><label>1</label><figDesc><div><p><s>Characteristics of returning travellers with skin and soft tissue infectionsData are number of subjects/bacterial isolates (column %) with given characteristic together with odds ratios (OR) and 95% confidence intervals (95% CI) from univariable logistic regression.</s><s>p values are testing H0: the odds of a given characteristic are equal in the two comparison groups.</s><s>p 0.05 shown in bold type.</s></p></div></figDesc><table><row><cell></cell><cell cols="5">All skin and soft tissue infections, n [ 318</cell><cell></cell><cell cols="7">Staphylococcus aureus-positive skin and soft tissue infections, n [ 196</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>S. aureus</cell><cell></cell><cell>other</cell><cell></cell><cell></cell><cell></cell><cell>PVL+</cell><cell></cell><cell>PVL−</cell><cell></cell><cell></cell><cell></cell><cell>MRSA</cell><cell></cell><cell>MSSA</cell><cell></cell><cell></cell></row><row><cell>Characteristic</cell><cell cols="2">(n [ 196) (%)</cell><cell cols="2">(n [ 122) (%)</cell><cell>OR (95% CI)</cell><cell>p</cell><cell cols="2">(n [ 122) (%)</cell><cell cols="2">(n [ 74) (%)</cell><cell>OR (95% CI)</cell><cell>p</cell><cell cols="2">(n [ 23) (%)</cell><cell cols="2">(n [ 173) (%)</cell><cell>OR (95% CI)</cell><cell>p</cell></row><row><cell>Female Age in years (range) a</cell><cell>77 31 (23-45)</cell><cell cols="2">(39) 52 35.5 (25-51)</cell><cell cols="2">(43) 0.9 (0.5-1.4) 0.9 (0.8-1.0)</cell><cell>0.6 0.07</cell><cell>51 31 (23-46)</cell><cell cols="2">(42) 26 30 (24-44)</cell><cell cols="2">(35) 1.3 (0.7-2.4) 1.0 (0.9-1.2)</cell><cell>0.4 0.7</cell><cell>11 28 (22-39)</cell><cell>(48)</cell><cell>(24-45)</cell><cell cols="2">(38) 1.5 (0.6-3.6) 0.8 (0.6-1.1)</cell><cell>0.4 0.1</cell></row><row><cell>Travel characteristics Destination b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Latin America</cell><cell>32</cell><cell cols="2">(16) 15</cell><cell cols="2">(12) 1.4 (0.7-2.7)</cell><cell>0.3</cell><cell>25</cell><cell cols="2">(21) 7</cell><cell cols="2">(10) 2.5 (1.0-6.0)</cell><cell>0.05</cell><cell>10</cell><cell>(44)</cell><cell></cell><cell cols="2">(13) 5.3 (2.1-13.5)</cell><cell>0.001</cell></row><row><cell>Africa</cell><cell>64</cell><cell cols="2">(33) 38</cell><cell cols="2">(31) 1.1 (0.7-1.7)</cell><cell>0.8</cell><cell>47</cell><cell cols="2">(39) 17</cell><cell cols="2">(23) 2.1 (1.1-4.0)</cell><cell>0.03</cell><cell>3</cell><cell>(13)</cell><cell></cell><cell cols="2">(35) 0.3 (0.1-1.0)</cell><cell>0.04</cell></row><row><cell>South Asia</cell><cell>32</cell><cell cols="2">(16) 29</cell><cell cols="2">(24) 0.6 (0.4-1.1)</cell><cell>0.1</cell><cell>20</cell><cell cols="2">(16) 12</cell><cell cols="2">(16) 1.0 (0.5-2.2)</cell><cell>1.0</cell><cell>2</cell><cell>(9)</cell><cell></cell><cell cols="2">(17) 0.5 (0.1-2.0)</cell><cell>0.3</cell></row><row><cell>South-East Asia Australia/Pacific Duration in days d Purpose e</cell><cell>57 8 28 (17-109)</cell><cell cols="2">(29) 35 (4) 3 30 (17-90)</cell><cell cols="2">(29) 1.0 (0.6-1.7) (2) 1.7 (0.4-6.5) 1.0 (0.99-1.02)</cell><cell>0.9 0.5 0.4</cell><cell>27 2 28.5 (17-116)</cell><cell cols="2">(22) 30 (2) 6 28 (19-88)</cell><cell cols="2">(41) 0.4 (0.2-0.8) (8) 0.2 (0.04-1.0) 1.0 (0.99-1.01)</cell><cell cols="2">0.007 8 0.05 0 0.5 31 (20-194)</cell><cell>(35) (0)</cell><cell>(17-100)</cell><cell cols="3">(28) 1.3 (0.5-3.4) (5) -1.0 (0.99-1.01) 0.7 0.5 0.3 c</cell></row><row><cell>Leisure Business/education</cell><cell>109 17</cell><cell cols="2">(56) 81 (9) 12</cell><cell cols="2">(66) 0.6 (0.4-1.0) (10) 0.9 (0.4-1.9)</cell><cell>0.06 0.7</cell><cell>61 13</cell><cell cols="2">(50) 48 (11) 4</cell><cell cols="2">(65) 0.5 (0.3-1.0) (5) 2.1 (0.7-6.7)</cell><cell>0.04 0.2</cell><cell>10 0</cell><cell>(43) (0)</cell><cell></cell><cell cols="2">(57) 0.6 (0.2-1.4) (10) -</cell><cell>0.2 0.1 c</cell></row><row><cell>Humanitarian/VFR Clinical characteristics f</cell><cell>69</cell><cell cols="2">(35) 29</cell><cell cols="2">(24) 1.7 (1.0-2.9)</cell><cell>0.03</cell><cell>47</cell><cell cols="2">(39) 22</cell><cell cols="2">(30) 1.5 (0.8-2.7)</cell><cell>0.2</cell><cell>13</cell><cell>(57)</cell><cell></cell><cell cols="2">(32) 2.7 (1.1-6.6)</cell><cell>0.03</cell></row><row><cell>Type of lesion</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ulcer</cell><cell>53</cell><cell cols="2">(27) 57</cell><cell cols="2">(47) 0.4 (0.3-0.7)</cell><cell cols="2">&lt;0.001 12</cell><cell cols="2">(10) 41</cell><cell cols="2">(56) 0.1 (0.0-0.2)</cell><cell cols="2">&lt;0.001 2</cell><cell>(9)</cell><cell></cell><cell cols="2">(30) 0.2 (0.1-1.0)</cell><cell>0.05</cell></row><row><cell>Furuncle/abscess</cell><cell>132</cell><cell cols="2">(67) 56</cell><cell cols="2">(46) 2.4 (1.5-3.9)</cell><cell cols="2">&lt;0.001 105</cell><cell cols="2">(86) 27</cell><cell cols="4">(36) 10.8 (5.4-21.6) &lt;0.001 19</cell><cell>(83)</cell><cell></cell><cell cols="2">(65) 2.5 (0.8-7.8)</cell><cell>0.1</cell></row><row><cell>Other</cell><cell>10</cell><cell>(5)</cell><cell>9</cell><cell>(7)</cell><cell>0.7 (0.3-1.7)</cell><cell>0.4</cell><cell>5</cell><cell>(4)</cell><cell>5</cell><cell>(7)</cell><cell>0.6 (0.2-2.1)</cell><cell>0.4</cell><cell>2</cell><cell>(9)</cell><cell></cell><cell>(5)</cell><cell>2.0 (0.4-9.9)</cell><cell>0.4</cell></row><row><cell>Deep lesion</cell><cell>85</cell><cell cols="2">(43) 40</cell><cell cols="2">(33) 1.6 (1.0-2.5)</cell><cell>0.07</cell><cell>71</cell><cell cols="2">(58) 14</cell><cell cols="2">(19) 6.0 (3.0-11.8)</cell><cell cols="2">&lt;0.001 11</cell><cell>(48)</cell><cell></cell><cell cols="2">(43) 1.2 (0.5-2.9)</cell><cell>0.6</cell></row><row><cell>Preceding trauma</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>None</cell><cell>109</cell><cell cols="2">(56) 48</cell><cell cols="2">(40) 1.9 (1.2-3.1)</cell><cell cols="2">0.006 79</cell><cell cols="2">(66) 30</cell><cell cols="2">(41) 2.8 (1.5-5.0)</cell><cell cols="2">0.001 14</cell><cell>(61)</cell><cell></cell><cell cols="2">(56) 1.2 (0.5-3.0)</cell><cell>0.7</cell></row><row><cell>Insect bites</cell><cell>62</cell><cell cols="2">(32) 50</cell><cell cols="2">(42) 0.7 (0.4-1.0)</cell><cell>0.08</cell><cell>35</cell><cell cols="2">(29) 27</cell><cell cols="2">(37) 0.7 (0.4-1.3)</cell><cell>0.3</cell><cell>6</cell><cell>(26)</cell><cell></cell><cell cols="2">(33) 0.7 (0.3-1.9)</cell><cell>0.5</cell></row><row><cell>Other</cell><cell>22</cell><cell cols="2">(11) 21</cell><cell cols="2">(18) 0.8 (0.6-1.1)</cell><cell>0.1</cell><cell>6</cell><cell>(5)</cell><cell>16</cell><cell cols="2">(22) 0.4 (0.3-0.7)</cell><cell cols="2">0.001 3</cell><cell>(13)</cell><cell></cell><cell cols="2">(11) 1.1 (0.6-2.1)</cell><cell>0.8</cell></row><row><cell>Recurrent episodes</cell><cell>70</cell><cell cols="2">(36) 29</cell><cell cols="2">(24) 1.8 (1.1-3.0)</cell><cell>0.03</cell><cell>55</cell><cell cols="2">(45) 15</cell><cell cols="2">(20) 3.2 (1.7-6.3)</cell><cell cols="2">0.001 13</cell><cell>(57)</cell><cell></cell><cell cols="2">(33) 2.6 (1.1-6.4)</cell><cell>0.03</cell></row><row><cell>Surgical drainage</cell><cell>66</cell><cell cols="2">(34) 19</cell><cell cols="2">(16) 2.7 (1.5-4.8)</cell><cell cols="2">0.001 61</cell><cell cols="2">(50) 5</cell><cell>(7)</cell><cell cols="3">13.8 (5.2-36.6) &lt;0.001 12</cell><cell>(52)</cell><cell></cell><cell cols="2">(31) 2.4 (1.0-5.8)</cell><cell>0.05</cell></row><row><cell cols="2">Antibiotics prescribed 155</cell><cell cols="2">(79) 102</cell><cell cols="2">(84) 0.8 (0.4-1.4)</cell><cell>0.4</cell><cell>100</cell><cell cols="2">(83) 55</cell><cell cols="2">(74) 1.6 (0.8-3.3)</cell><cell>0.2</cell><cell>19</cell><cell>(83)</cell><cell></cell><cell cols="2">(79) 1.3 (0.4-3.9)</cell><cell>0.7</cell></row><row><cell>Contacts affected</cell><cell>34</cell><cell cols="2">(18) 16</cell><cell cols="2">(13) 1.4 (0.7-2.7)</cell><cell>0.3</cell><cell>22</cell><cell cols="2">(18) 12</cell><cell cols="2">(16) 1.2 (0.5-2.5)</cell><cell>0.7</cell><cell>8</cell><cell>(33)</cell><cell></cell><cell cols="2">(16) 2.5 (0.9-6.7)</cell><cell>0.07</cell></row><row><cell>Hospitalization due to</cell><cell>25</cell><cell cols="2">(13) 14</cell><cell cols="2">(12) 1.1 (0.6-2.3)</cell><cell>0.7</cell><cell>22</cell><cell cols="2">(18) 3</cell><cell>(4)</cell><cell>5.2 (1.5-18.2)</cell><cell cols="2">0.009 5</cell><cell>(22)</cell><cell></cell><cell cols="2">(12) 2.1 (0.7-6.2)</cell><cell>0.2</cell></row><row><cell>travel-associated SSTI Location of lesion g</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Below waistline</cell><cell>129</cell><cell cols="2">(70) 83</cell><cell cols="2">(74) 1</cell><cell></cell><cell>69</cell><cell cols="2">(60) 60</cell><cell cols="2">(87) 1</cell><cell></cell><cell>10</cell><cell>(50)</cell><cell></cell><cell cols="2">(73) 1</cell></row><row><cell>Above waistline</cell><cell>55</cell><cell cols="2">(30) 29</cell><cell cols="2">(26) 1.2 (0.7-2.1)</cell><cell>0.5</cell><cell>46</cell><cell cols="2">(40) 9</cell><cell cols="2">(13) 4.4 (2.0-9.8)</cell><cell cols="2">&lt;0.001 10</cell><cell>(50)</cell><cell></cell><cell cols="2">(27) 2.6 (1.0-6.8)</cell><cell>0.04</cell></row></table><note><p><s>Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; PVL, Panton-Valentine leukocidin; VFR, visiting friends and relatives.</s><s>a Median (inter quartile range); odds ratios per 10 years increase in age.</s><s>b Row category of cases with other destinations (Turkey, Mongolia, Afghanistan, Azerbaijan, USA) not displayed.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2 .</head><label>2</label><figDesc><div><p><s>Phenotypic and genotypic characteristics of imported Staphylococcus aureus by place of exposure</s></p></div></figDesc><table><row><cell>Travel to</cell></row><row><cell>Characteristic a</cell></row></table><note><p><s>Data are number (column %) of isolates with given resistance phenotype, clonal complex, and most common spa-type within a given clonal complex.</s><s>Odds ratios (OR) and 95% confidence intervals (CI) were derived from univariable logistic regression.</s><s>Confidence intervals excluding an OR of 1.0 are given in bold.</s><s>Abbreviations: CC, Spa clonal complex; MRSA, methicillin-resistant S. aureus; SXT, trimethoprim-sulfamethoxazole.</s><s>Spa types clustering in CC's were: CC2 (t002, t311, t088), CC21/318 (t021, t019, t318), CC34 (t034, t571), CC84 (t084), CC272 (t159, t645); CC24/304 (t008, t024 t701), CC345 (t345), CC355 (t355).</s><s>Only strata of genotypes containing five or more isolates and showing a significant geographic association are displayed.</s><s>a The column category 'other regions' containing one isolate each from Afghanistan, Azerbaijan and the USA was omitted from this table.</s><s>b Rows and columns showing frequencies of resistance to gentamicin (n = 5) imported from India (n = 2), Thailand, Zambia, Afghanistan and to rifampicin (n = 1) imported from Thailand were omitted from this table.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3 .</head><label>3</label><figDesc><div><p><s>Travel-associated import of methicillin-resistant Staphylococcus aureus to Europe</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>spa</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>No.</cell><cell>Travel clinic</cell><cell>Sex</cell><cell>Age</cell><cell>Purpose</cell><cell>Region</cell><cell>Country</cell><cell>Type</cell><cell>CC</cell><cell>PVL</cell><cell>SCCmec</cell><cell>Co-resistance a</cell></row><row><cell>1 2 3 4 5 6 7 8</cell><cell>Helsinki Berlin Basel Amsterdam Würzburg Berlin ITM Tübingen ITM Tübingen</cell><cell>M F F F M M M F</cell><cell>59 6 25 2 47 18 36 23</cell><cell>Leisure VFR Aid work Leisure VFR VFR VFR Aid work</cell><cell>Latin America</cell><cell>Colombia Colombia Colombia Suriname Cuba Bahamas Costa Rica Costa Rica</cell><cell>t008 b t008 b t13392 t008 d t008 d t008 d t148 t10437</cell><cell>24/304 24/304 Singleton 24/304 24/304 24/304 No founder e No founder e</cell><cell>Pos. Pos. Pos. Pos. Pos. Pos. Pos. Pos.</cell><cell>IVc IVc n/t c IVa IVa IVa IVa IVa</cell><cell>CIP ERY None SXT, ERY, CIP ERY, CIP ERY None None</cell></row><row><cell>9 10</cell><cell>Basel Berlin</cell><cell>F M</cell><cell>28 27</cell><cell>Leisure Leisure</cell><cell></cell><cell>Jamaica Panama</cell><cell>t024 t2393</cell><cell>24/304 No founder f</cell><cell>Pos. Pos.</cell><cell>IVc IVc</cell><cell>SXT None</cell></row><row><cell>11 12 13</cell><cell>ITM Tübingen PLK Tübingen Paris</cell><cell>F M M</cell><cell>24 49 29</cell><cell>Aid work Aid work Leisure</cell><cell>Africa</cell><cell>South Africa South Sudan Madagascar</cell><cell>t3812 t008 c t186</cell><cell>Excluded 24/304 No founder f</cell><cell>Pos. Pos. Pos.</cell><cell>IVc IVc IVa</cell><cell>None TET None</cell></row><row><cell>14</cell><cell>Vienna</cell><cell>F</cell><cell>39</cell><cell>Leisure</cell><cell>South Asia</cell><cell>India</cell><cell>t657</cell><cell>345</cell><cell>Pos.</cell><cell>V</cell><cell>ERY, CIP, GM</cell></row><row><cell>15</cell><cell>PLK Tübingen</cell><cell>F</cell><cell>21</cell><cell>Aid work</cell><cell></cell><cell>India</cell><cell>t304</cell><cell>24/304</cell><cell>Pos.</cell><cell>IVa</cell><cell>SXT, CIP</cell></row><row><cell>16</cell><cell>Hamburg</cell><cell>F</cell><cell>23</cell><cell>Aid work</cell><cell>South-East Asia</cell><cell>Thailand</cell><cell>t202</cell><cell>Singleton</cell><cell>Pos.</cell><cell>IVa</cell><cell>None</cell></row><row><cell>17 18</cell><cell>ITM Tübingen ITM Tübingen</cell><cell>M M</cell><cell>32 31</cell><cell>Leisure Leisure</cell><cell></cell><cell>Thailand Thailand</cell><cell>t1671 t008 e</cell><cell>Singleton 24/304</cell><cell>Pos. Pos.</cell><cell>IVa IVa</cell><cell>ERY ERY</cell></row><row><cell>19</cell><cell>ITM Tübingen</cell><cell>M</cell><cell>22</cell><cell>Aid work</cell><cell></cell><cell>The Philippines</cell><cell>t019</cell><cell>21</cell><cell>Pos.</cell><cell>IVc</cell><cell>None</cell></row><row><cell>20</cell><cell>Paris</cell><cell>M</cell><cell>54</cell><cell>Leisure</cell><cell></cell><cell>The Philippines</cell><cell>t002</cell><cell>2</cell><cell>Pos.</cell><cell>IVc</cell><cell>CC, ERY, TET</cell></row><row><cell>21</cell><cell>PLK Tübingen</cell><cell>F</cell><cell>31</cell><cell>VFR</cell><cell></cell><cell>The Philippines</cell><cell>t019</cell><cell>21</cell><cell>Pos.</cell><cell>IVc</cell><cell>None</cell></row><row><cell>22</cell><cell>Berlin</cell><cell>F</cell><cell>46</cell><cell>Leisure</cell><cell></cell><cell>The Philippines</cell><cell>n/t</cell><cell>-</cell><cell>Neg.</cell><cell>IVc</cell><cell>SXT</cell></row><row><cell>23</cell><cell>PLK Tübingen</cell><cell>M</cell><cell>19</cell><cell>Aid work</cell><cell></cell><cell>Vietnam</cell><cell>t202</cell><cell>Singleton</cell><cell>Pos.</cell><cell>IVa</cell><cell>None</cell></row><row><cell cols="3">All isolates tested positive for mecA.</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>Abbreviations: CC, spa clonal complex; f, female; ITM, Institute of Tropical Medicine; m, male; n/t, not typeable; PLK, Paul-Lechler Hospital; PVL, Panton-Valentine leukocidin; VFR, visiting friends and relatives.a</s><s>Resistance to the following additional antibacterial drugs was tested; trimethoprim-sulfamethoxazole (SXT), clindamycin (CC), erythromycin (ERY), ciprofloxacin (CIP), gentamicin (GM), tetracycline (TET), rifampicin (RA).b</s><s>arcA-negative, consistent with USA300 Latin American Variant.c</s><s>By PCR for SCCmec types I-V.d arcA-positive, consistent with USA300-0114 lineage.e,f</s><s>These spa types belong to the same cluster with no founder.567.e6</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE 4 .</head><label>4</label><figDesc><div><p><s>Risk factors for Staphylococcus aureus, PVL-positive S. aureus, and MRSA nasal carriage in travellers with skin and soft tissue infections</s></p></div></figDesc><table><row><cell></cell><cell cols="3">S. aureus nasal carriage</cell><cell></cell><cell></cell><cell></cell><cell cols="5">PVL-positive S. aureus nasal carriage</cell><cell></cell><cell cols="2">MRSA nasal carriage</cell></row><row><cell></cell><cell>Yes</cell><cell></cell><cell>No</cell><cell></cell><cell></cell><cell></cell><cell>Yes</cell><cell></cell><cell>No</cell><cell></cell><cell></cell><cell></cell><cell>Yes</cell><cell>No</cell></row><row><cell>Characteristic</cell><cell cols="2">n [ 122 (%)</cell><cell cols="2">n [ 188 (%)</cell><cell>OR (95% CI)</cell><cell>p</cell><cell cols="2">n [ 53 (%)</cell><cell cols="2">n [ 257 (%)</cell><cell>OR (95% CI)</cell><cell>p</cell><cell cols="2">n [ 18 (%)</cell><cell>n [ 292 (%)</cell><cell>OR (95% CI)</cell><cell>p</cell></row><row><cell>Female Age in years a</cell><cell>(23-45)</cell><cell cols="2">(43) 74 31 (24-49)</cell><cell cols="2">(39) 1.1 (0.7-1.8) 0.9 (0.8-1.1)</cell><cell>0.6 0.3</cell><cell>24 31 (23-49)</cell><cell cols="2">(45) 102 31 (24-47)</cell><cell>40</cell><cell>1.3 (0.7-2.3) 1.0 (0.9-1.2)</cell><cell>0.5 0.8</cell><cell cols="2">11 29.5 (21-46) (61) 115 31 (24-48)</cell><cell>(39) 2.4 (0.9-6.4) 0.8 (0.6-1.1)</cell><cell>0.08 0.2</cell></row><row><cell>Travel characteristics Destination b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Latin America</cell><cell></cell><cell cols="2">(14) 30</cell><cell cols="2">(16) 0.9 (0.4-1.6)</cell><cell>0.6</cell><cell>9</cell><cell cols="2">(17) 38</cell><cell>15</cell><cell>1.2 (0.5-2.6)</cell><cell>0.7</cell><cell>6</cell><cell>(33) 41</cell><cell>(14) 3.1 (1.1-8.6)</cell><cell>0.03</cell></row><row><cell>Africa</cell><cell></cell><cell cols="2">(35) 58</cell><cell cols="2">(31) 1.2 (0.8-2.0)</cell><cell>0.4</cell><cell>20</cell><cell cols="2">(38) 81</cell><cell>32</cell><cell>1.3 (0.7-2.4)</cell><cell>0.4</cell><cell>1</cell><cell>(6)</cell><cell>100</cell><cell>(34) 0.1 (0.1-0.9)</cell><cell>0.04</cell></row><row><cell>South Asia</cell><cell></cell><cell cols="2">(21) 31</cell><cell cols="2">(16) 1.4 (0.8-2.4)</cell><cell>0.3</cell><cell>12</cell><cell cols="2">(23) 45</cell><cell>18</cell><cell>1.4 (0.7-2.8)</cell><cell>0.4</cell><cell>6</cell><cell>(33) 51</cell><cell>(17) 2.4 (0.8-6.6)</cell><cell>0.1</cell></row><row><cell>South-East Asia Australia/Pacific Duration in days d Purpose e</cell><cell>(20-112)</cell><cell cols="2">(27) 56 (2) 9 28 (17-83)</cell><cell cols="2">(30) 0.9 (0.5-1.5) (5) 0.3 (0.1-1.6) 1.01 (1.00-1.03)</cell><cell>0.6 0.2 0.2</cell><cell cols="3">11 1 63 (22-195) (21) 78 (2) 10 28 (17-83)</cell><cell>30 4</cell><cell>0.6 (0.3-1.2) 0.5 (0.1-3.8) 1.02 (1.00-1.04)</cell><cell>0.2 0.5 0.02</cell><cell cols="2">5 0 38 (21-305) (28) 84 (0) 11 28 (17-90)</cell><cell>(29) 1.0 (0.3-2.8) (4) -1.00 (1.00-1.01)</cell><cell>0.9 0.4 c 0.3</cell></row><row><cell>Leisure</cell><cell></cell><cell cols="2">(53) 119</cell><cell cols="2">(63) 0.7 (0.4-1.1)</cell><cell>0.08</cell><cell>23</cell><cell cols="2">(43) 161</cell><cell>63</cell><cell>0.5 (0.3-0.8)</cell><cell>0.01</cell><cell>8</cell><cell>(44) 176</cell><cell>(60) 0.5 (0.2-1.4)</cell><cell>0.2</cell></row><row><cell>Business/education</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>Data are number of subjects/bacterial isolates (column %) with given characteristic together with odds ratios (OR) and 95% confidence intervals (95% CI) from univariable logistic regression.</s><s>p values are testing H0: the odds of a given characteristic are equal in the two comparison groups.</s><s>p 0.05 in bold type.</s><s>Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; PVL, Panton-Valentine leukocidin; VFR, visiting friends and relatives.</s><s>No associations were detected between any of the types of nasal carriage with prescription of antibiotics, depth of lesion, and hospitalization because of travel-associated skin and soft tissue infection (not displayed).</s><s>Row category of cases with other destinations (Turkey, Mongolia, Afghanistan, Azerbaijan, USA) not displayed.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">.1-401.5) &lt;0.001</cell></row><row><cell>Ulcer</cell><cell cols="2">(31) 71</cell><cell cols="2">(38) 0.7 (0.5-1.2)</cell><cell>0.2</cell><cell>7</cell><cell cols="2">(13) 102</cell><cell>40</cell><cell>0.2 (0.1-0.5)</cell><cell cols="2">0.001 3</cell><cell cols="2">(17) 106</cell><cell cols="2">(36) 0.3 (0.1-1.2)</cell><cell>0.1</cell></row><row><cell>Furuncle/abscess</cell><cell cols="2">(61) 107</cell><cell cols="2">(57) 1.2 (0.7-1.9)</cell><cell>0.5</cell><cell>43</cell><cell cols="2">(81) 138</cell><cell>54</cell><cell>3.7 (1.8-7.7)</cell><cell cols="2">&lt;0.001 13</cell><cell cols="2">(72) 168</cell><cell cols="2">(58) 1.9 (0.7-5.5)</cell><cell>0.2</cell></row><row><cell>Other</cell><cell>(8)</cell><cell>9</cell><cell>(5)</cell><cell>1.8 (0.7-4.5)</cell><cell>0.2</cell><cell>3</cell><cell>(6)</cell><cell>16</cell><cell>6</cell><cell>0.9 (0.3-3.2)</cell><cell>0.9</cell><cell>2</cell><cell cols="2">(11) 17</cell><cell>(6)</cell><cell>2.0 (0.4-9.5)</cell><cell>0.4</cell></row><row><cell>Preceding trauma</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>None</cell><cell cols="2">(61) 80</cell><cell cols="2">(44) 2.0 (1.3-3.2)</cell><cell cols="2">0.003 40</cell><cell cols="2">(75) 113</cell><cell>45</cell><cell>3.8 (1.9-7.4)</cell><cell cols="2">&lt;0.001 12</cell><cell cols="2">(67) 141</cell><cell cols="2">(49) 2.1 (0.8-5.6)</cell><cell>0.2</cell></row><row><cell>Insect bites</cell><cell cols="2">(27) 76</cell><cell cols="2">(41) 0.5 (0.3-0.9)</cell><cell>0.01</cell><cell>11</cell><cell cols="2">(21) 97</cell><cell>39</cell><cell>0.4 (0.2-0.8)</cell><cell>0.02</cell><cell>5</cell><cell cols="2">(28) 103</cell><cell cols="2">(36) 0.7 (0.2-2.0)</cell><cell>0.5</cell></row><row><cell>Other</cell><cell cols="2">(13) 28</cell><cell cols="2">(15) 0.9 (0.6-1.2)</cell><cell>0.5</cell><cell>2</cell><cell>(4)</cell><cell>41</cell><cell>16</cell><cell>0.4 (0.2-0.9)</cell><cell>0.03</cell><cell>1</cell><cell>(6)</cell><cell>42</cell><cell cols="2">(15) 0.6 (0.2-1.6)</cell><cell>0.3</cell></row><row><cell>Recurrent episodes</cell><cell cols="2">(34) 56</cell><cell cols="2">(30) 1.2 (0.7-1.9)</cell><cell>0.5</cell><cell>24</cell><cell cols="2">(45) 73</cell><cell>28</cell><cell>2.1 (1.1-3.8)</cell><cell>0.02</cell><cell>8</cell><cell cols="2">(44) 89</cell><cell cols="2">(30) 1.8 (0.7-4.8)</cell><cell>0.2</cell></row><row><cell>Surgical drainage</cell><cell cols="2">(25) 52</cell><cell cols="2">(28) 0.9 (0.5-1.5)</cell><cell>0.6</cell><cell>21</cell><cell cols="2">(40) 62</cell><cell>24</cell><cell>2.1 (1.1-3.8)</cell><cell>0.02</cell><cell>7</cell><cell cols="2">(39) 76</cell><cell cols="2">(26) 1.8 (0.7-4.8)</cell><cell>0.2</cell></row><row><cell>Contacts affected Location of lesion g</cell><cell cols="2">(18) 28</cell><cell cols="2">(15) 1.2 (0.7-2.3)</cell><cell>0.5</cell><cell>10</cell><cell cols="2">(20) 39</cell><cell>15</cell><cell>1.4 (0.6-2.9)</cell><cell>0.4</cell><cell>6</cell><cell cols="2">(35) 43</cell><cell cols="2">(15) 4.1 (1.1-9.0)</cell><cell>0.03</cell></row><row><cell>Below waistline</cell><cell cols="2">(68) 129</cell><cell cols="2">(74) Ref.</cell><cell></cell><cell>24</cell><cell cols="2">(52) 182</cell><cell>75</cell><cell>Ref.</cell><cell></cell><cell>8</cell><cell cols="2">(53) 198</cell><cell cols="2">(72) Ref.</cell></row><row><cell>Above waistline</cell><cell cols="2">(32) 46</cell><cell cols="2">(26) 1.3 (0.8-2.3)</cell><cell>0.3</cell><cell>22</cell><cell cols="2">(48) 61</cell><cell>25</cell><cell>2.7 (1.4-5.2)</cell><cell cols="2">0.002 7</cell><cell cols="2">(47) 76</cell><cell cols="2">(28) 2.3 (0.8-6.5)</cell><cell>0.1</cell></row></table><note><p><s>a Median (inter quartile range); odds ratios per 10 years increase in age.</s><s>b</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>TABLE 5 .</head><label>5</label><figDesc><div><p><s>Risk factors for antibiotic multi-resistance in imported Staphylococcus aureus (column %) of subjects/bacterial isolates with given characteristic together with odds ratios (OR) and 95% confidence intervals (95% CI).</s><s>p-values are testing H0: the odds of a given characteristic are equal in the two comparison groups.</s></p></div></figDesc><table><row><cell>Characteristic Female Age in years d Travel characteristics e Destination f Latin America Africa South Asia South-East Asia Australia/Pacific Clinical characteristics g Deep lesion Systemic inflammation h 20 Multi-resistance to  ‡ 2 of all tested compounds a Yes No OR (95% CI) p n [ 54 (%) n [ 142 (%) 24 (44) 53 (37) 1.3 (0.7-2.5) 0.4 33 (21-49) 30 (24-43) 1.0 (0.8-1.3) h 0.8 9 (17) 23 (16) 1.0 (0.4-2.4) 0.9 13 (24) 51 (36) 0.6 (0.3-1.2) 0.1 17 (31) 15 (11) 3.9 (1.8-8.5) 0.001 17 Multi-resistance to  ‡ 2 non-β-lactam antibiotics b Yes No OR (95% CI) p n [ 46 (%) n [ 150 (%) 21 (46) 56 (37) 1.4 (0.7-2.7) 33.5 (21-50) 30 (24-44) 1.0 (0.8-1.3) 5 (11) 27 (18) 0.6 (0.2-1.5) 12 (26) 52 (35) 0.7 (0.3-1.4) (37) 15 (10) 5.3 (2.4-11.8) &lt;0.001 3.8 (1.5-9.5) Multivariable analysis c OR (95% CI) p 0.3 0.7 0.3 0.3 0.004 13 (24) 44 (31) 0.7 (0.3-1.4) 0.3 10 (22) 47 (31) 0.6 (0.3-1.3) 0.2 2 (4) 6 (4) 0.8 (0.2-4.5) 0.9 2 (4) 6 (4) 1.1 (0.2-5.6) 0.9 28 (52) 57 (40) 1.6 (0.9-3.0) 0.1 26 (57) 59 (39) 2.0 (1.0-3.9) 0.04 (38) 36 (26) 1.8 (09-3.4) 0.1 18 (40) 38 (26) 1.9 (1.0-3.9) 0.07 Recurrent episodes 24 (44) 46 (32) 1.7 (0.9-3.2) 0.1 20 (43) 50 (33) 1.5 (0.8-3.0) 0.2 Surgical drainage 26 (48) 40 (28) 2.4 (1.2-4.5) 0.009 23 (50) 43 (29) 2.5 (1.3-4.9) 0.008 Hospitalization due to travel-associated SSTI 11 (20) 14 (10) 2.3 (1.0-5.4) 0.06 9 (20) 16 (11) 2.0 (0.8-4.9) 0.1 S. aureus characteristics PVL-positivity 42 (78) 80 (56) 2.7 (1.3-5.6) 0.007 35 (76) 87 (58) 2.3 (1.1-4.9) 0.03 mecA-positivity 13 (24) 10 (7) 4.2 (1.7-10.3) 0.002 5 (11) 18 (12) 0.9 (0.3-2.6) 0.8 Spa-type i t021 9 (17) 2 (1) 14.0 (2.9-67.2) 0.001 9 (20) 2 (1) 18.0 (3.7-86.9) &lt;0.001 9.3 (1.7-50.0) 0.009 t008 8 (15) 4 (3) 6.0 (1.7-20.9) 0.005 3 (7) 9 (6) 1.1 (0.3-4.2) 0.9 t355 5 (9) 5 (4) 2.8 (0.8-10.1) 0.1 5 (11) 5 (3) 3.5 (1.0-12.8) 0.05 5.7 (1.5-21.2) 0.01 Data are n 567.e8 Clinical Microbiology and Infection, Volume 21 Number 6, June 2015</cell></row></table><note><p><s>Abbreviations: mecA, gene conferring methicillin resistance in S. aureus; PVL, Panton-Valentine leukocidin; SSTI, skin and soft tissue infection.a</s><s>Namely, resistance to two or more of trimethoprim-sulfamethoxazole, tetracycline, ciprofloxacin, clindamycin, gentamicin, rifampicin, erythromycin, methicillin; definition reflecting multi-resistance to empiric therapy of S. aureus SSTI.b</s><s>Namely, resistance to two or more of trimethoprim-sulfamethoxazole, tetracycline, ciprofloxacin, clindamycin, gentamicin, rifampicin, erythromycin; definition reflecting multiresistance to empiric therapy of suspected MRSA SSTI.c Results of multivariable logistic regression modelling the independent effect of spa t355, spa t021, and travel to South Asia on multi-resistance to two or more non-β-lactam antibiotics.d</s><s>Median (interquartile range); odds ratios per 10 years increase in age.e</s><s>No association detected for purpose or duration of travel.f</s><s>Row category of cases with other destinations (Turkey, Mongolia, Afghanistan, Azerbaijan, USA) not displayed.g</s><s>No association detected for type of lesion, preceding trauma, SSTI in contacts, antibiotics prescribed.h</s><s>Defined as any of fever, blood leukocytosis, or elevated serum level of C-reactive protein.i</s><s>No associations detected for any of the other spa-types.</s><s>CMI Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases.</s><s>Published by Elsevier Ltd.</s><s>All rights reserved, CMI, 21, 567.e1-567.e10</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 567.e1-567.e10</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank the TropNet (www.tropnet.net)</s><s>and EuroTravNet (www.istm.org/eurotravnet)</s><s>networks in tropical medicine and travel health for their support in identifying member sites for the StaphTrav network.</s><s>Additional members of the StaphTrav network who contributed cases (in alphabetical order) are: Johannes Blum, Basel; Antonia Calvo, Barcelona; Jacob P. Cramer, Hamburg; Julian Gabor, Tübingen; Marika Gaile, Tübingen; Heimo Lagler, Wien; Hans-Dieter Nothdurft, München; Michael Ramharter, Wien; Thierry Rolling, Hamburg; Günther Slesak, Tübingen; Florian Steiner, Berlin; and Uwe Ziegler, Würzburg.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Funding</head><p><s>This work was supported by the Institute of Tropical Medicine, Tübingen, Germany; Institute of Public Health, Heidelberg University Hospital, Heidelberg, Germany; and the Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University Hospital, Heidelberg, Germany.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transparency declaration</head><p><s>All authors have stated that there are no conflicts of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Appendix A. Supplementary data</head><p><s>Supplementary data related to this article can be found online at http://dx.doi.org/10.1016/j.cmi.2015.01.016.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Freedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">H</forename><surname>Weld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Kozarsky</surname></persName>
		</author>
		<imprint>
			<pubPlace>Fisk T, Robins R, von</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Spectrum of disease and relation to place of exposure among ill returned travelers</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sonnenburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">354</biblScope>
			<biblScope unit="page" from="119" to="130" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Skin and soft tissue infections in returning travelers</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hochedez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Canestri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lecso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Valin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bricaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Caumes</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Trop Med Hyg</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="431" to="434" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Staphylococcus aureus positive skin infections and international travel</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zanger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Wien Klin Wochenschr</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="31" to="33" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Suppl. 1</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Recurrent furunculosis in returning travelers: newly defined entity</title>
		<author>
			<persName><forename type="first">O</forename><surname>Artzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sinai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schwartz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Travel Med</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="21" to="25" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Panton-Valentine leukocidinproducing methicillin-Sensitive Staphylococcus aureus as a cause for recurrent, contagious skin infections in young, healthy travelers returned from a tropical country: a new worldwide public health problem?</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Schleucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gaessler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Knobloch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Travel Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="137" to="139" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Import and spread of Panton-Valentine leukocidinpositive Staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zanger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nurjadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schleucher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scherbaum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wolz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Kemsner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="483" to="492" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Community-associated methicillin-resistant Staphylococcus aureus infections</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Cooke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br Med Bull</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="215" to="227" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary</title>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Cosgrove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Fridkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gorwitz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Kaplan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="285" to="292" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Stevens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Bisno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Chambers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Dellinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Gorbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="e10" to="52" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Molecular typing of Staphylococcus aureus on the basis of coagulase gene polymorphisms</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Goh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Byrne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Chow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1642" to="1645" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Testing for induction of clindamycin resistance in erythromycin-resistant isolates of Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Steward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Raney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Morrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Mcdougal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Jevitt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="1716" to="1721" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mcclure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Conly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elsayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Louie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hutchins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="1141" to="1144" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">A simplified multiplex PCR assay for fast and easy discrimination of globally distributed staphylococcal cassette chromosome mec types in meticillin-resistant Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ghaznavi-Rad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nor</forename><surname>Shamsudin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sekawi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Van Belkum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Microbiol</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="1135" to="1139" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Novel multiplex PCR assay for simultaneous identification of community-associated methicillin-resistant Staphylococcus aureus strains USA300 and USA400 and detection of mecA and Panton-Valentine leukocidin genes, with discrimination of Staphylococcus aureus from coagulase-negative staphylococci</title>
		<author>
			<persName><forename type="first">K</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mcclure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elsayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Louie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Conly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1118" to="1122" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management</title>
		<author>
			<persName><forename type="first">D</forename><surname>Harmsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Claus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rothganger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Turnwald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Vogel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="5442" to="5448" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Based Upon Repeat Pattern (BURP): an algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mellmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Weniger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Berssenbrugge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rothgänger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sammeth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stoye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Microbiol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">98</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Comparing pulsed-field gel electrophoresis with multilocus sequence typing, spa typing, staphylococcal cassette chromosome mec (SCCmec) typing, and PCR for panton-valentine leukocidin, arcA, and opp3 in methicillin-resistant Staphylococcus aureus isolates at a U.S. Medical Center</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lynfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Boxrud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Short</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zychowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="814" to="819" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Nimmo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="725" to="734" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Bartels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kristoffersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Boye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Westh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="78" to="83" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Genome sequencing and molecular characterisation of Staphylococcus aureus ST772-MRSA-V</title>
		<author>
			<persName><forename type="first">S</forename><surname>Monecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Baier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Coombs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Slickers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ziegler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ehricht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Res Notes</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page">548</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Bengal Bay Clone</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America</title>
		<author>
			<persName><forename type="first">J</forename><surname>Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rincon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Diaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Panesso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Contreras</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zurita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="1861" to="1867" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Molecular epidemiology of Panton-Valentine leukocidin-positive Staphylococcus aureus in Spain: emergence of the USA300 clone in an autochthonous population</title>
		<author>
			<persName><forename type="first">R</forename><surname>Blanco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tristan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ezpeleta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Larsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Etienne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="433" to="436" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Shallcross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fragaszy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Hayward</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet Infect Dis</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="43" to="54" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Antimicrobial resistance: not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician&apos;s guide to community MRSA -its evolving antimicrobial resistance and implications for therapy</title>
		<author>
			<persName><forename type="first">K</forename><surname>Chua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Coombs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Grayson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">P</forename><surname>Howden</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="99" to="114" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Methicillin-Resistant Staphylococcus aureus and intercontinental travel-&quot;bad bugs on the move!</title>
		<author>
			<persName><forename type="first">P</forename><surname>Zanger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Travel Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="225" to="227" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The role of international travel in the spread of methicillin-resistant Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wilder-Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Y</forename><surname>Hsu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Travel Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="272" to="281" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to</title>
		<author>
			<persName><forename type="first">D</forename><surname>Nurjadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Olalekan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Layer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Shittu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alabi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ghebremedhin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Europe. J Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="2361" to="2368" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIVpositive individuals in</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Olalekan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schaumburg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nurjadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Dike</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ojurongbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Kolawole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Antimicrob Agents</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="268" to="272" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Global distribution and evolution of Panton-Valentine leukocidinpositive methicillin-susceptible Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Rasigade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Laurent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Meugnier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vandenesch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="1589" to="1597" />
			<date type="published" when="1981">1981-2007. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Contribution of genetically restricted, methicillinsusceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Orscheln</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hunstad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Fritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Loughman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Storch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="536" to="542" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kearns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Morrison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Grundmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Edwards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="1256" to="1258" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mönecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Slickers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Ellington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kearns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ehricht</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Infect</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1157" to="1164" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Frequent emergence and limited geographic dispersal of methicillinresistant Staphylococcus aureus</title>
		<author>
			<persName><forename type="first">U</forename><surname>Nübel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Roumagnac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Feldkamp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="14130" to="14135" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
